Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (original) (raw)

• Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
  Article CAS PubMed Google Scholar
• Zitvogel, L. et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87–97 (1996).
  Article CAS PubMed Google Scholar
• Zitvogel, L. et al. IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann. NY Acad. Sci. 795, 284–293 (1996).
  Article CAS PubMed Google Scholar
• Mayordomo, J.I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1, 1297–1302 (1995).
  Article CAS PubMed Google Scholar
• Nestle, F.O., Banchereau, J. & Hart, D. Dendritic cells: on the move from bench to bedside. Nat. Med. 7, 761–765 (2001).
  Article CAS PubMed Google Scholar
• Hsu, F.J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2, 52–58 (1996).
  Article CAS PubMed Google Scholar
• Pardoll, D. T cells and tumors. Nature 411, 1010–1012 (2001).
  Article CAS PubMed Google Scholar
• Zou, W. et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7, 1339–1346 (2001).
  Article CAS PubMed Google Scholar
• Gabrilovich, D.I. et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2, 1096–1103 (1996).
  Article CAS PubMed Google Scholar
• Dong, H., Zhu, G., Tamada, K. & Chen, L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5, 1365–1369 (1999).
  Article CAS PubMed Google Scholar
• Tamura, H. et al. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97, 1809–1816 (2001).
  Article CAS PubMed Google Scholar
• Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793–800 (2002).
  Article CAS PubMed Google Scholar
• Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765–772 (1996).
  Article CAS PubMed Google Scholar
• Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151 (1999).
  Article CAS PubMed Google Scholar
• Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319–322 (2001).
  Article CAS PubMed Google Scholar
• Mazanet, M.M. & Hughes, C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169, 3581–3588 (2002).
  Article CAS PubMed Google Scholar
• Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. & Enk, A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159, 4772–4780 (1997).
  CAS PubMed Google Scholar
• Loercher, A.E., Nash, M.A., Kavanagh, J.J., Platsoucas, C.D. & Freedman, R.S. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J. Immunol. 163, 6251–6260 (1999).
  CAS PubMed Google Scholar
• Carmeliet, P. & Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).
  Article CAS PubMed Google Scholar
• Menetrier-Caux, C. et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778–4791 (1998).
  CAS PubMed Google Scholar
• Bennett, S.R. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478–480 (1998).
  Article CAS PubMed Google Scholar
• Ridge, J.P., Di Rosa, F. & Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474–478 (1998).
  Article CAS PubMed Google Scholar
• Schoenberger, S.P., Toes, R.E., van der Voort, E.I., Offringa, R. & Melief, C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480–483 (1998).
  Article CAS PubMed Google Scholar
• Chang, C.C. et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237–243 (2002).
  Article CAS PubMed Google Scholar
• Trinchieri, G. & Scott, P. Interleukin-12: basic principles and clinical applications. Curr. Top. Microbiol. Immunol. 238, 57–78 (1999).
  CAS PubMed Google Scholar
• Dong, H. et al. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 111:363–370, 2003
  Article CAS PubMed PubMed Central Google Scholar
• Wang, S.-D. et al. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. In press.
• Takahashi, A. et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54, 4233–4237 (1994).
  CAS PubMed Google Scholar
• Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. & Ellis, L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55, 3964–3968 (1995).
  CAS PubMed Google Scholar
• Brown, L.F. et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143, 1255–1262 (1993).
  CAS PubMed PubMed Central Google Scholar
• Toi, M. et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77, 1101–1106 (1996).
  Article CAS PubMed Google Scholar
• Zou, W. et al. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by β-chemokines rather than IL-12. J. Immunol. 165, 4388–4396 (2000).
  Article CAS PubMed Google Scholar
• Zou, W. et al. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay. Eur. Cytokine Netw. 6, 257–264 (1995).
  CAS PubMed Google Scholar
• Strome, S.E. et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62, 1884–1889 (2002).
  CAS PubMed Google Scholar
• Llorente, L. et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181, 839–844 (1995).
  Article CAS PubMed Google Scholar
• Mesiano, S., Ferrara, N. & Jaffe, R.B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol. 153, 1249–1256 (1998).
  Article CAS PubMed PubMed Central Google Scholar